Yumei Jia
No. 8, Gongti South Road, Chaoyang District
Beijing, 100020, China
Beijing, 100020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Risk Factors for Nonalcoholic Fatty Liver Disease with Different Insulin Resistance in a Nonobese Chinese Population.
Journal: Journal of diabetes research
Published: August 31, 2022
Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism.
Journal: International journal of endocrinology
Published: August 07, 2021
Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
Journal: Journal of diabetes research
Published: June 07, 2021
Non-linear associations of body mass index with impaired fasting glucose, β-cell dysfunction, and insulin resistance in nondiabetic Chinese individuals: a cross-sectional study.
Journal: Endokrynologia Polska
Published: March 31, 2021
SERUM METABOLOMIC PATTERNS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: September 27, 2019
Levothyroxine Replacement Alleviates Thyroid Destruction in Hypothyroid Patients With Autoimmune Thyroiditis: Evidence From a Thyroid MRI Study.
Journal: Frontiers in endocrinology
Published: December 22, 2018
Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.
Journal: Shock (Augusta, Ga.)
Published: April 28, 2018
Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes.
Journal: International journal of endocrinology
Published: May 07, 2017
The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department.
Journal: The American journal of emergency medicine
Published: February 19, 2017
PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 07, 2017
Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 19, 2016
Last Updated: 09/26/2026